Sall4 Regulates Cell Fate Decision in Fetal Hepatic Stem/Progenitor Cells
Tsunekazu Oikawa(University of North Carolina at Chapel Hill), Hiromitsu Nakauchi(Japan Science and Technology Agency), Ryuichi Nishinakamura(Kumamoto Industrial Research Institute), Akihide Kamiya(The University of Tokyo), Hisao Tajiri(Jikei University School of Medicine), Mikio Zeniya(International University of Health and Welfare), Sei Kakinuma(The University of Tokyo)
Cited by 106
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer
|The EMBO Journal|1999|423
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|271
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
|Hepatology|2012|195